Set Analyses:
Advanced Search

Advanced Search

 
Search By
Section (entire)
for


 
or upload a file of gene symbols


Category   Symbol Source: HGNC EntrezGene Ensembl GeneCards RNA genes CroW21
GIFtS

HLA-DRA Gene

protein-coding   GIFtS: 64
GCID: GC06P032412

major histocompatibility complex, class II, DR alpha


(Previous symbol: HLA-DRA1)
 Explore 60 diseases affiliated with
HLA-DRA via our new
 Human Malady Compendium 
Biological research products
for HLA-DRA
    

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, and/or 10fRNAdb)
About This Section

Aliases
Major Histocompatibility Complex, Class II, DR Alpha1 2     Histocompatibility Antigen HLA-DR Alpha2
HLA-DRA11 2 3     HLA Class II Histocompatibility Antigen, DR Alpha Chain2
MHC Class II Antigen DRA2 3     MHC Cell Surface Glycoprotein2
MLRW2     

External Ids:    HGNC: 49471   Entrez Gene: 31222   Ensembl: ENSG000002042877   OMIM: 1428605   UniProtKB: P019033   

Export aliases for HLA-DRA gene to outside databases

Previous GC identifers: GC06P032434 GC06Pd32422 GC06P032178


(According to Entrez Gene, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

Entrez Gene summary for HLA-DRA:
HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an
alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting
peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B
lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons.
Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the
transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as
the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. (provided by RefSeq, Jul 2008)

UniProtKB/Swiss-Prot: DRA_HUMAN, P01903
Function: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and
presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides
of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins
that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous
antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and
for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their
way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal
compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a
source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition
to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74
and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an
antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the
ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen
processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a
small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM
via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules
until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported
to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by
HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the
regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and
efficient peptide loading

Gene Wiki entry for HLA-DRA


(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 69), Regulatory elements and Epigenetics data according to QIAGEN, SABiosciences, and/or SwitchGear Genomics)
About This Section
RefSeq DNA sequence:
NC_000006.11  NC_018917.1  NT_007592.15  NT_113891.2  NT_167245.1  NT_167246.1  NT_167247.1  NT_167248.1  
NT_167249.1  
Regulatory elements:
   SABiosciences Regulatory transcription factor binding sites in the HLA-DRA gene promoter:
         Pax-5   AML1a   GCNF   CUTL1   Arnt   AREB6   IRF-2   GCNF-1   Pax-4a   GCNF-2   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmidHLA-DRA promoter sequence
   Search SABiosciences Chromatin IP Primers for HLA-DRA

Epigenetics:
QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat HLA-DRA


Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: 6p21.3   Ensembl cytogenetic band:  6p21.32   HGNC cytogenetic band: 6p21.3

HLA-DRA Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
HLA-DRA gene location

GeneLoc information about chromosome 6         GeneLoc Exon Structure

GeneLoc location for GC06P032412:  view genomic region     (about GC identifiers)

Start:
32,407,619 bp from pter      End:
32,412,823 bp from pter
Size:
5,205 bases      Orientation:
plus strand

6 alternative locations:
Chr6+,ALT_REF_LOCI_6 32,365,090-32,405,881      Chr6+,ALT_REF_LOCI_5 32,397,816-32,403,026      Chr6+,ALT_REF_LOCI_3 32,382,335-32,398,583     
Chr6+,ALT_REF_LOCI_4 32,369,338-32,374,549      Chr6+,ALT_REF_LOCI_2 32,355,870-32,400,225      Chr6+,ALT_REF_LOCI_7 32,343,748-32,348,958     

(According to 1UniProtKB, HORDE, neXtProt, Ensembl, and/or Reactome, Modification sites according to 2PhosphoSitePlus, Specific Peptides from DME, Protein expression images according to data from SPIRE MOPED and PaxDb, RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, and/or Uscn,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, and/or Uscn, Ontologies according to Gene Ontology Consortium 01 Mar 2013 and Entrez Gene, Antibodies by EMD Millipore, R&D Systems, GenScript, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, Abcam, and/or Uscn)
About This Section

UniProtKB/Swiss-Prot: DRA_HUMAN, P01903 (See protein sequence)
Recommended Name: HLA class II histocompatibility antigen, DR alpha chain precursor  
Size: 254 amino acids; 28607 Da
Subunit: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmic
reticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariant
chain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoes
sequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHC
class II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding of
antigenic peptides
Subcellular location: Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass
type I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosome
membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Late endosome
membrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number of
intracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation
Sequence caution: Sequence=CAA25076.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
6/58 PDB 3D structures from and Proteopedia for HLA-DRA (see all 58):
1A6A (3D)        1AQD (3D)        1BX2 (3D)        1D5M (3D)        1D5X (3D)        1D5Z (3D)    
Secondary accessions: A2BET4 Q30160 Q6IAZ1 Q861I2 Q9TP70

Explore the universe of human proteins at neXtProt for HLA-DRA: NX_P01903

Post-translational modifications:

  • Ubiquitinated by MARCH1 or MARCH8 at Lys-244 leading to down-regulation of MHC class II. When associated with
  • ubiquitination of the beta subunit of HLA-DR: HLA-DRB4 'Lys-254', the down-regulation of MHC class II may be highly
    effective1
  • View modification sites using PhosphoSitePlus2
  • View neXtProt modification sites for NX_P01903

  • HLA-DRA Protein expression data from MOPED and PaxDb:    About this image 
    Estimated protein expression log10 (pmol).

    REFSEQ proteins: NP_061984.2  
    ENSEMBL proteins: 
     ENSP00000378786   ENSP00000364121  
    Reactome Protein details: P01903
    Human Recombinant Protein Products: 
    Browse Purified and Recombinant Proteins at EMD Millipore
    Browse R&D Systems for human recombinant proteins
    Browse recombinant and purified proteins available from Enzo Life Sciences
    Browse OriGene full length recombinant human proteins expressed in human HEK293 cells
    OriGene Protein Over-expression Lysate: HLA-DRA
    OriGene Custom Protein Services for HLA-DRA 
    GenScript Custom Purified and Recombinant Proteins Services for HLA-DRA
    Novus Biologicals HLA-DRA Lysates
    Browse Sino Biological Recombinant Proteins
    Browse ProSpec Recombinant Proteins
    Browse Proteins at Uscn

    Gene Ontology (GO): 5/16 cellular component terms (GO ID links to tree view) (see all 16):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0000139Golgi membrane TAS--
    GO:0005764lysosome IDA8890155
    GO:0005765lysosomal membrane TAS--
    GO:0005789endoplasmic reticulum membrane ----
    GO:0005794Golgi apparatus ----


    HLA-DRA for ontologies           About GeneDecksing



    HLA-DRA Antibody Products: 
    Browse EMD Millipore's Extensive Line of Mono- and Polyclonal Antibodies
    R&D Systems Antibodies for HLA-DRA (HLA-DR)
    OriGene Antibodies: HLA-DRA
    OriGene Custom Antibody Services for HLA-DRA 
    GenScript Custom Superior Antibodies Services for HLA-DRA
    Novus Biologicals HLA-DRA Antibodies
    Abcam antibodies for HLA-DRA 
    Browse Antibodies at Uscn
    Search ThermoFisher Antibodies for HLA-DRA

    Assay Products for HLA-DRA: 
    Browse Kits and Assays available from EMD Millipore
    OriGene Custom Immunoassay Development
    Browse OriGene Fluorogenic Cell Assay Kits
    Browse R&D Systems for biochemical assays
    GenScript Custom Assay Services for HLA-DRA
    Browse Enzo Life Sciences for kits & assays
    Browse ELISAs and CLIAs at Uscn


    (According to InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section

    HLA-DRA for domains           About GeneDecksing

    5/7 InterPro domains/families (see all 7):
     IPR001003 MHC_II_a_N
     IPR011162 MHC_I/II-like_Ag-recog
     IPR013783 Ig-like_fold
     IPR014745 MHC_II_a/b_N
     IPR003597 Ig_C1-set

    Graphical View of Domain Structure for InterPro Entry P01903

    ProtoNet protein and cluster: P01903

    2 Blocks protein families:
    IPB001003 MHC Class II alpha chain
    IPB003597 Immunoglobulin C-type


    UniProtKB/Swiss-Prot: DRA_HUMAN, P01903
    Similarity: Belongs to the MHC class II family
    Similarity: Contains 1 Ig-like C1-type (immunoglobulin-like) domain


    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013,
    bound targets from SABiosciences, miRNA Gene Targets from miRTarBase shRNA from OriGene, RNAi from EMD Millipore, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, Gene Editing from DNA2.0, Clones from EMD Millipore, OriGene, SwitchGear Genomics, GenScript, Sino Biological, DNA2.0, and Vector BioLabs, Cell Lines from GenScript, LifeMap BioReagents, In Situ Hybridization Assays from Advanced Cell Diagnostics, Ontologies according to Gene Ontology Consortium 01 Mar 2013 via Entrez Gene.)
    About This Section

    Function Summary:

         UniProtKB/Swiss-Prot: DRA_HUMAN, P01903
    Function: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and
    presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides
    of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins
    that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous
    antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and
    for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their
    way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal
    compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a
    source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition
    to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74
    and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an
    antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the
    ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen
    processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a
    small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM
    via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules
    until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported
    to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by
    HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the
    regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and
    efficient peptide loading

         Genatlas biochemistry entry for HLA-DRA:
    HLA-DR,alpha chain

    miRNA
    Products:
        
    OriGene 3'-UTR Clone: HLA-DRA
    Browse MicroRNA Expression Plasmids
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat HLA-DRA
    4 QIAGEN miScript miRNA Assays for microRNAs that regulate HLA-DRA:
    hsa-miR-942 hsa-miR-875-3p hsa-miR-525-5p hsa-miR-520a-5p
    SwitchGear 3'UTR luciferase reporter plasmidHLA-DRA 3' UTR sequence
    Inhib. RNA
    Products:
        
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for HLA-DRA
    OriGene shRNA RFP: HLA-DRA
    OriGene siRNA: HLA-DRA
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat HLA-DRA

    Gene Editing
    Products:
    DNA2.0 Custom Protein Engineering Service for HLA-DRA

    Clone
    Products:
         
    Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
    OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRA
    OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRA (see all 2)
    OriGene custom cloning services – gene synthesis, subcloning, mutagenesis, variant library, vector shuttling 
    GenScript: all cDNA clones in your preferred vector: HLA-DRA (NM_019111)
    Browse Sino Biological Human cDNA Clones
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for HLA-DRA
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat HLA-DRA 

    Cell Line
    Products:
         
    GenScript Custom overexpressing Cell Line Services for HLA-DRA
    Search LifeMap BioReagents cell lines for HLA-DRA

    In Situ Assay
    Products:
       

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for HLA-DRA

    Gene Ontology (GO): 1 molecular function term (GO ID links to tree view):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0032395MHC class II receptor activity NAS6812963


    HLA-DRA for ontologies           About GeneDecksing


    2 GenomeRNAi human phenotypes for HLA-DRA:
     Increased G1 DNA content  Synthetic lethal with imatinib 


    (Pathways according to EMD Millipore, R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to SABiosciences, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Mar 2013 via Entrez Gene).
    About This Section

    Unified GeneCards pathways - 5/36 super-pathways (see all 36About this table 
    See pathways by source

    Super-pathwaycontained gene-specific pathways
    1Allograft rejection
    8/10 pathways (see all 10)
    Allograft rejection1.00
    THC Differentiation Pathway0.39
    Type I diabetes mellitus0.67
    CTL Mediated Apoptosis0.38
    Graft-versus-host disease0.63
    Intestinal immune network for IgA production0.38
    Autoimmune thyroid disease0.60
    Viral myocarditis0.33
    2Transport of MHC II:Ii complex along Golgi to TGN
    Transport of MHC II:Ii complex to plasma membrane1.00
    Trafficking of nonameric complex in the endocytic pathway1.00
    Transport of MHC II:Ii complex along Golgi to TGN1.00
    Internalization of MHC II:Ii clathrin coated vesicle0.52
    Insertion of MHC II:Ii complex in to the plasma membrane1.00
    3Translocation of ZAP-70 to Immunological synapse
    Translocation of ZAP-70 to Immunological synapse1.00
    PD-1 signaling0.76
    Phosphorylation of CD3 and TCR zeta chains0.85
    Generation of second messenger molecules0.64
    4ICos-ICosL Pathway in T-Helper Cell
    ICos-ICosL Pathway in T-Helper Cell1.00
    Calcium Mediated T-Cell Apoptosis0.31
    CD28 Signaling in T-Helper Cell0.66
    5PKC-Theta Pathway
    PKC-Theta Pathway1.00
    ITK and TCR Signaling0.54
    TCR Signaling0.68

    Pathway sources
    See GeneCards unified pathways
    Show all pathways

    5/6 EMD Millipore Pathways for HLA-DRA (see all 6)
        Immune response Antigen presentation by MHC class II
    G-protein signaling N-RAS regulation pathway
    Immune response IL-22 signaling pathway
    Immune response NFAT in immune response
    Immune response ICOS pathway in T-helper cell

    3 R&D Systems Pathways for HLA-DRA
        IL-21 Signaling and its Primary Biological Effects in Different Immune Cell Types
    Th1 Differentiation
    Th17 Differentiation

    5/12 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for HLA-DRA (see all 12)
        THC Differentiation Pathway
    Calcium Mediated T-Cell Apoptosis
    IL-4 Pathway
    ICos-ICosL Pathway in T-Helper Cell
    CDC42 Pathway

    5/6 GeneGo (Thomson Reuters) Pathways for HLA-DRA (see all 6)
        Immune response Antigen presentation by MHC class II
    Immune response ICOS pathway in T-helper cell
    Immune response T cell receptor signaling pathway
    Immune response IL-22 signaling pathway
    G-protein signaling N-RAS regulation pathway

    5 BioSystems Pathways for HLA-DRA 
        Cytokines and Inflammatory Response
    IL12-mediated signaling events
    TCR signaling in naive CD4+ T cells
    CXCR4-mediated signaling events
    IL12 signaling mediated by STAT4

    5/20        Reactome Pathways for HLA-DRA (see all 20)
        Internalization of MHC II:Ii clathrin coated vesicle
    Costimulation by the CD28 family
    Transport of MHC II:Ii complex along Golgi to TGN
    Transport of MHC II:Ii complex to plasma membrane
    Transport of antigen loaded MHC II molecules to surface


    5/18         Kegg Pathways  (Kegg details for HLA-DRA) (see all 18):
        Phagosome
    Cell adhesion molecules (CAMs)
    Antigen processing and presentation
    Hematopoietic cell lineage
    Intestinal immune network for IgA production


    HLA-DRA for pathways           About GeneDecksing

    Interactions:

        SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for HLA-DRA

    STRING Interaction Network Preview (showing 5 interactants - click image to see 9)

    5/28 Interacting proteins for HLA-DRA (P019032, 3 ENSP000003787864) via UniProtKB, MINT, STRING, and/or I2D (see all 28)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    CD74P042332, 3, ENSP000000095304MINT-72789 I2D: score=2 STRING: ENSP00000009530
    ENSG00000206306P019122, 3MINT-24910 I2D: score=1 
    HLA-DRB1P019122, 3, ENSP000003530994I2D: score=1 I2D: score=1 MINT-24881 I2D: score=2 MINT-24910 I2D: score=1 I2D: score=1 STRING: ENSP00000353099
    CD63P089623, ENSP000002578574I2D: score=3 STRING: ENSP00000257857
    MBPP026863, ENSP000003482734I2D: score=2 STRING: ENSP00000348273
    About this table

    Gene Ontology (GO): 5/7 biological process terms (GO ID links to tree view) (see all 7):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0002504antigen processing and presentation of peptide or polysaccharide antigen via MHC class II ----
    GO:0006955immune response NAS6812963
    GO:0019221cytokine-mediated signaling pathway TAS--
    GO:0019886antigen processing and presentation of exogenous peptide antigen via MHC class II TAS--
    GO:0031295T cell costimulation TAS--


    HLA-DRA for ontologies           About GeneDecksing



    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience HMDB, BitterDB, and/or Novoseek, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB, with drugs/clinical trials/news search links to CenterWatch)
    About This Section

    HLA-DRA for compounds           About GeneDecksing

    Browse Small Molecules at EMD Millipore
    Browse drugs & compounds from Enzo Life Sciences

    Browse Tocris compounds for HLA-DRA
    1 Novoseek chemical compound relationship for HLA-DRA gene    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    chloramphenicol 10.9 1 1454841 (1)

    Search CenterWatch for drugs/clinical trials and news about HLA-DRA / DRA 

    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 235 Homo sapiens; Mar 10 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    RNAi Products from EMD Millipore,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN,
    Tagged/untagged cDNA clones from OriGene, SwitchGear Genomics, GenScript, DNA2.0, Vector BioLabs, Primers from OriGene, SABiosciences, and/or QIAGEN )
    About This Section

    REFSEQ mRNAs for HLA-DRA gene: 
    NM_019111.4  

    Unigene Cluster for HLA-DRA:

    Major histocompatibility complex, class II, DR alpha
    Hs.520048  [show with all ESTs]
    Unigene Representative Sequence: BQ057851
    3 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000395388(uc003obh.3 uc003obi.3) ENST00000462200 ENST00000374982


    miRNA
    Products:
         
    OriGene 3'-UTR Clone: HLA-DRA
    Browse OriGene MicroRNA Expression Plasmids
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat HLA-DRA
    4 QIAGEN miScript miRNA Assays for microRNAs that regulate HLA-DRA:
    hsa-miR-942 hsa-miR-875-3p hsa-miR-525-5p hsa-miR-520a-5p
    SwitchGear 3'UTR luciferase reporter plasmidHLA-DRA 3' UTR sequence
    Inhib. RNA
    Products:
         
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for HLA-DRA
    OriGene shRNA RFP: HLA-DRA
    OriGene siRNA: HLA-DRA
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat HLA-DRA
    Clone
    Products:
         
    OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRA
    OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRA (see all 2)
    OriGene custom cloning services – gene synthesis, subcloning, mutagenesis, variant library, vector shuttling 
    GenScript: all cDNA clones in your preferred vector: HLA-DRA (NM_019111)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for HLA-DRA
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat HLA-DRA 
    Primer
    Products:
        
    OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for HLA-DRA
    Browse OriGene validated miRNA SYBR primer pairs
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat HLA-DRA
      QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat HLA-DRA
      QIAGEN QuantiFast Probe-based Assays in human, mouse, rat HLA-DRA

    Additional cDNA sequence: 

    AK297032.1 AK301134.1 AK301354.1 AK304429.1 AK310161.1 AK313123.1 BC032350.1 BC071659.1 
    CR457013.1 J00194.1 J00195.1 J00197.1 K01171.1 M35979.1 M60333.1 M60334.1 
    V00523.1 V00528.1 

    24/50 DOTS entries (see all 50):

    DT.85105175  DT.456002  DT.95158848  DT.121341027  DT.91983131  DT.100684470  DT.100059742  DT.100857584 
    DT.91882867  DT.121340976  DT.91982743  DT.121340984  DT.121340896  DT.100857051  DT.86847432  DT.100684466 
    DT.121340956  DT.121341004  DT.95158819  DT.100857583  DT.91982410  DT.91695661  DT.95089770  DT.121341006 

    17 AceView cDNA sequences:

    CR613451 CR596644 J00197 CR590143 CR594558 CR622870 V00528 K01171 
    J00195 BV183551 CR457013 V00523 BC071659 M35979 BV204329 J00194 
    AF522250 

    GeneLoc Exon Structure


    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, plus additional links to Genevestigator, and/or SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from SABiosciences, Primers from OriGene, SABiosciences, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    HLA-DRA expression in normal human tissues (normalized intensities)
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS
    CGAP TAG: GGGCATCTCT

    Microarray
    RNAseq (Illumina Body Map)
    (100×FPKM)½
    SAGE (Serial Analysis of Gene Expression)

    About this image

    HLA-DRA expression in embryonic tissues and stem cells
    Expression by the Database of Embryonic development, Stem cell research, and Regenerative medicine    About this table
    3 LifeMap In Vivo Development Anatomical Compartments/Cells 
    Tissue Anatomical Compartment CellCategory (developmental path)
    Skeletal MuscleHyoid Arch MusclesMononuclear MyocytesSkeletal Muscle
    Skeletal MuscleMandibular Arch MusclesMononuclear MyocytesSkeletal Muscle
    Umbilical CordUmbilical VeinsUmbilical Cord
    Expression: Positive    Negative     Selective marker
    Experimental details: Curated     Microarrays     In-situ hybridization

    See HLA-DRA Protein Expression from SPIRE MOPED and PaxDB
    Genevestigator expression for HLA-DRA

    SOURCE GeneReport for Unigene cluster: Hs.520048
        SABiosciences Expression via Pathway-Focused PCR Array including HLA-DRA: 
              Cell Surface Markers in human mouse rat

    Primer
    Products:
    OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for HLA-DRA
    Browse OriGene validated miRNA SYBR primer pairs
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat HLA-DRA
    QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat HLA-DRA
    QIAGEN QuantiFast Probe-based Assays in human, mouse, rat HLA-DRA
    In Situ
    Assay Products:
     

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for HLA-DRA

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    This gene was present in the common ancestor of chordates.

    Orthologs for HLA-DRA gene from 3/10 species (see all 10)    About this table
    Organism Taxonomic
    classification
    Gene Description Human
    Similarity
    Orthology
    Type
    Details
    chicken
    (Gallus gallus)
    Aves B-LA1 MHC class II antigen alpha 58.26(n)
    51.33(a)
      414855  NM_001001762.1  NP_001001762.1 
    lizard
    (Anolis carolinensis)
    Reptilia --
    --
    --
    56(a)
    53(a)
    many ↔ many
    many ↔ many
    GL343775.1(36865-38243)
    GL343809.1(2435-3996)
    zebrafish
    (Danio rerio)
    Actinopterygii si:dkeyp-2h4.26
    si:ch1073-403i13.16
    (see all 10)
    si:ch1073-403i13.1
    (see all 10)
    30(a)
    29(a)
    (see all 10)
    many ↔ many
    many ↔ many
    (see all 10)
    8(37539907-37543263)
    8(37574076-37576393)


    ENSEMBL Gene Tree for HLA-DRA (if available)
    TreeFam Gene Tree for HLA-DRA (if available) 

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68)
    About This Section
    Paralogs for HLA-DRA gene
    HLA-DRB52  HLA-DQA12  HLA-DPA12  HLA-DQB12  HLA-DOB2  HLA-DRB12  HLA-DMA2  HLA-DQB22  
    HLA-DOA2  ENSG000002489932  HLA-DMB2  HLA-DQA22  HLA-DPB12  
    14 SIMAP similar genes for HLA-DRA using alignment to 12 protein entries:     DRA_HUMAN (see all proteins):
    HLA-DRA1    HLA-DQA1/DRA    HLA-DQA2    HLA-DPA1    DQA1-0103    HLA-DQA1
    HLA-DOA    DQ-A1    DMA    HLA-DMA    HLA-DRB1    HLA-DRB4
    B2M    HLA-B

    HLA-DRA for paralogs           About GeneDecksing



    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD) and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers from QIAGEN, Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
    About This Section

    UniProtKB/Swiss-Prot: DRA_HUMAN, P01903
    Polymorphism: The following alleles of DRA are known: DRA*01:01 and DRA*01:02. The sequence shown is that of DRA*01:01
    Polymorphism: Genetic variations in HLA-DRA influence susceptibility to hepatitis B virus (HBV) infection [MIM:610424]


    10/230 NCBI SNPs in HLA-DRA are shown (see all 230    About this table
    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    significance
    Chr 6 posSequence#AA
    Chg
    TypeMore#Allele
    freq
    PopTotal
    sample
    More
    ----------
    rs31298691,2
    C,F,A,H,--32405671(+) CTTTAC/ACTTTC 1 -- us2k115Minor allele frequency- A:0.38NS EA NA WA 1178
    rs38348571,2
    C,--32405693(+) TCCTG-/AAAAAT 1 -- us2k10--------
    rs1895567531,2
    --32405733(+) TCTAGC/TGATCT 1 -- us2k10--------
    rs92686271,2
    C,F,A,--32405821(+) TAACTT/CGTGAG 1 -- us2k17Minor allele frequency- C:0.16NA WA EA 502
    rs69397871,2
    C,F,H,--32405835(+) GGCTGC/TATGGC 1 -- us2k15Minor allele frequency- T:0.02NS EA WA 528
    rs92686281,2
    C,F,A,H,--32405865(+) ACAGTA/CTGGAA 1 -- us2k1 tfbs320Minor allele frequency- C:0.21NS EA NA WA 1694
    rs1144743271,2
    C,F,--32405894(+) ATGTCA/TTGACT 1 -- us2k11Minor allele frequency- T:0.03NA 120
    rs132192101,2
    C,--32406046(+) AAAATC/ACAAAA 1 -- us2k11Minor allele frequency- A:0.50NA 2
    rs92686291,2
    C,--32406085(+) TGGCCG/TGGCAT 1 -- us2k11Minor allele frequency- T:0.00NA 2
    rs31298701,2
    C,F,H,--32406100(+) GCGGGC/TGCCTG 1 -- us2k12Minor allele frequency- T:0.50NA 4

    HapMap Linkage Disequilibrium report for HLA-DRA (32407619 - 32412823 bp)
    Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions)
    Database of Genomic Variants (DGV): 5 variations for HLA-DRA
         5 CNVs: 7567 69434 3603 4493 64476
    Human Gene Mutation Database (HGMD): HLA-DRA

    Locus Specific Mutation Databases (LSDB): HLA-DRA

    SABiosciences Cancer Mutation PCR Assays
    QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing HLA-DRA
    DNA2.0 Custom Variant and Variant Library Synthesis for HLA-DRA

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section

    HLA-DRA for disorders           About GeneDecksing

    OMIM gene information: 142860    OMIM disorders: --

    20/60 diseases for HLA-DRA (see all 60):    About MalaCards
    mhc class ii deficiency    diffuse large b-cell lymphoma    graft versus host disease    herpetic keratitis
    non-small cell lung carcinoma    lichen planus    b-cell lymphomas    oral lichen planus
    type 1 diabetes mellitus    myasthenia gravis    ankylosing spondylitis    allergic encephalomyelitis
    systemic lupus erythematosus    acute promyelocytic leukemia    lupus erythematosus    diabetes mellitus
    keratitis    transitional cell carcinoma    multiple sclerosis    acute myeloid leukemia

    6 Novoseek disease relationships for HLA-DRA gene    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    carcinoma non-small cell lung 45.7 1 16360016 (1)
    retinoblastoma 45.5 2 9396821 (1), 11533238 (1)
    necrosis 0 2 1454841 (1)
    tumors 0 7 11533238 (3), 1454841 (1), 15688398 (1)
    lymphoma 0 1 9352360 (1)
    cancer 0 2 8170082 (1)

    Genetic Association Database (GAD): HLA-DRA
    Human Genome Epidemiology (HuGE) Navigator: HLA-DRA (53 documents)

    Export disorders for HLA-DRA gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    PubMed articles for HLA-DRA gene, integrated from 9 sources (see all 294):
    (articles sorted by number of sources associating them with HLA-DRA)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. The HLA-DRA*0102 allele: correct nucleotide sequence and associated HLA haplotypes. (PubMed id 12445311)1, 2, 9 Kralovicova J....Vorechovsky I. (2002)
    2. The HLA-DRalpha chain is modified by polyubiquitination. (PubMed id 19117940)1, 2 Lapaque N....Kelly A.P. (2009)
    3. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. (PubMed id 18305173)1, 2 De Gassart A....Gatti E. (2008)
    4. Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3. (PubMed id 15836703)1, 4 Gow P....Mutimer D. (2005)
    5. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. (PubMed id 15301866)1, 4 Donmez B....Idiman E. (2004)
    6. Microgeographic variation of HLA-A, -B, and -DR haplotype frequencies in Tuscany, Italy: implications for recruitment of bone marrow donors. (PubMed id 15361126)1, 4 Marroni F....Presciuttini S. (2004)
    7. Genetic basis of the latex-fruit syndrome: association with HLA class II alleles in a Spanish population. (PubMed id 15536412)1, 4 Blanco C....Carrillo T. (2004)
    8. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)1, 2 Gerhard D.S....Malek J. (2004)
    9. The DNA sequence and analysis of human chromosome 6. (PubMed id 14574404)1, 2 Mungall A.J.... Beck S. (2003)
    10. Evidence for human leukocyte antigen-related susceptibility in idiopathic childhood ischemic stroke. (PubMed id 12373032)1, 4 Zou L.P....Mix E. (2002)

    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section
     ANDOR
    Aliases
    Disorders
    Free Text  

      Query String
    PubMed
    OMIM
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)

    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, Kegg, and/or H-InvDB)
    About This Section
    Entrez Gene: 3122 HGNC: 4947 AceView: HLA-DRA.1 Ensembl:ENSG00000204287 euGenes: HUgn3122
    ECgene: HLA-DRA Kegg: 3122 H-InvDB: HLA-DRA

    (According to HUGE)
    About This Section
      --

    (According to PharmGKB, ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL,
    Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot)
    About This Section
    NameDescription
    PharmGKB entry for HLA-DRA Pharmacogenomics, SNPs, Pathways

    (Patent information from GeneIP,
    Licensable technologies from WIS Yeda, Salk, Tufts,
    IP news from LifeMap Sciences, Inc.)
    About This Section
    Patent Information for HLA-DRA gene:
    Search GeneIP for patents involving HLA-DRA

    GeneCards and IP:
    Japan Patent Office Licenses GeneCards     European Patent Office Licenses GeneCards     Improving the IP Search



    (Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Uscn, Thermo Fisher Scientific, Gene Editing from DNA2.0, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Cell lines from GenScript and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or Enzo Life Sciences),
    In Situ Hybridization Assays from
    Advanced Cell Diagnostics
    About This Section

     
     EMD Millipore Custom Antibody & Bulk Services
     EMD Millipore Preclinical / Clinical Development Services
     EMD Millipore Immunoassay Services
     EMD Millipore Target Screening & Profiling Services

      
     Antibodies for HLA-DRA (HLA-DR)   Browse Cell Culture Products  
     Browse ELISAs   Browse Flow Cytometry Kits  
     Browse Primer Pairs   Browse Kinase Activity Assays/Reagents  
     Browse ELISpot Kits/Development Modules   Browse TFB/Immunoprecipitation Assays  
     Browse Apoptosis Detection Kits/Reagents   Browse Ubiquitin Proteasome Pathway (UPP) Assay Kits/Reagents  
     Browse DNA Damage/Repair Kits/Reagents   Browse Multiplex/Array Assay Kits/Reagents  
     Browse Cell Selection/Detection Kits/Reagents   Browse Secondary Antibodies/Controls/Staining Reagents  
     Browse Phosphatase Activity Assays/Reagents   Browse Recombinant/Natural Proteins  
     OriGene Antibodies for HLA-DRA   OriGene shRNA RFP for HLA-DRA  
     OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for HLA-DRA   OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for HLA-DRA  
     OriGene Protein Over-expression Lysate for HLA-DRA   Browse OriGene Fluorogenic Cell Assay Kits  
     OriGene siRNA for HLA-DRA   OriGene 3'-UTR Clone for HLA-DRA  
     OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRA   OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for HLA-DRA  
     Browse OriGene GFP tagged cDNA clones in CMV expression vector   Browse OriGene MicroRNA Expression Plasmids  
     Browse OriGene basic RS shRNAs   Browse OriGene validated miRNA SYBR primer pairs  
     Browse OriGene full length recombinant human proteins expressed in human HEK293 cells   OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling  
     OriGene Custom Antibody Services for HLA-DRA   OriGene Custom Protein Services for HLA-DRA  
     OriGene Custom Immunoassay Development  

     
     
     QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat HLA-DRA
     QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing HLA-DRA
     QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat HLA-DRA
     QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat HLA-DRA
     QIAGEN QuantiFast Probe-based Assays in human, mouse, rat HLA-DRA
     QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat HLA-DRA
     GenScript Custom Purified and Recombinant Proteins Services for HLA-DRA GenScript cDNA clones with any tag delivered in your preferred vector for HLA-DRA
     GenScript Custom Assay Services for HLA-DRA GenScript Custom Superior Antibodies Services for HLA-DRA
     GenScript Custom overexpressing Cell Line Services for HLA-DRA CloneReady with Over 120,000 Genes
     Gene Synthesis: Any Gene in Any Vector Vector-based siRNA and miRNA, Ready for Transfection
     Gene Mutant Library, Variants up to 10^11 Plasmid Preparation
     Custom Peptide Services
     Search for Antibodies & Assays

     Regulatory tfbs in HLA-DRA promoter
     Search Chromatin IP Primers for HLA-DRA
     RT2 qPCR Primer Assay in human, mouse, rat HLA-DRA
     GNC Network for HLA-DRA
     SABiosciences PCR Arrays including human, mouse, rat HLA-DRA
     Search Tocris compounds for HLA-DRA
     Browse Sino Biological Proteins and Antibodies
     Browse Sino Biological cDNA Clones
     Antibodies/Proteins Production Services
     Rabbit Monoclonal Antibody Platform
     Bulk Purchasing
     Search www.enzolifesciences.com for proteins, assays, substrates, inhibitors & antibodies
     Novus Tissue Slides
     HLA-DRA antibodies
     HLA-DRA lysates
     Antibodies for HLA-DRA
     See all of Abcam's Antibodies, Kits and Proteins for HLA-DRA
     Custom Antibody / Protein Production Service
     Bulk Purchasing
     Advantages of Rabbit Monoclonal antibodies
     Abcam protocols and scientific support
     Browse ProSpec Recombinant Proteins




     Browse ELISAs, CLIAs, Proteins, and Antibodies at Uscn
     Search LifeMap BioReagents cell lines for HLA-DRA
     Gene Synthesis
     Protein Engineering
     Variant Library Synthesis
     Codon Optimization
     Protein Production and Purification
     Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for HLA-DRA
     SwitchGear 3'UTR luciferase reporter plasmids for HLA-DRA
     SwitchGear Promoter luciferase reporter plasmids for HLA-DRA
     Search ThermoFisher Antibodies for HLA-DRA
     Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat HLA-DRA
           
    GeneCards Homepage - Last full update: 19 Mar 2013 - Incrementals: 21 Mar 2013 , 15 Apr 2013 , 26 Apr 2013

    View Random Gene

    Category
    VWF
    (GIFTS: 73)
    von Willebrand factor
    GIFtS Group
    The GeneCards human gene database gene index: 1 3 5 6 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 


    Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

    Hot genes      Disease genes      HLA-DRA gene at Home site.
    hostname: 356980-web2.xennexinc.com index build: 100 solr: 1.4